TNG-462

Biorbyt

TNG-462

10

Research Use Only

98.00%

C28H36N6O2S

520.69

TNG-462 (Compound 1143) is an orally active PRMT5 inhibitor under investigation for the treatment of MTAP-deficient and/or MTA-accumulating cancers [1].

C(C(NC=1C=C(CC)C(N)=NC1)=O)(=O)N2[C@H](CC[C@H](C)C2)C=3C=C4C(=CC3)SC(=N4)C5CCN(C)CC5

-20°C

12352200